Journal of Clinical Neurology · Nov 2026
White-Matter Hyperintensities and Cognitive Function in Adults With Cardiovascular-Kidney-Metabolic Syndrome
By Shen FC, Lin YT, Lin MY et al.
BACKGROUND AND PURPOSE: Cardiovascular-kidney-metabolic (CKM) syndrome is associated with cognitive impairment and cerebral small-vessel disease, but the relationship between the white-matter hyperintensity (WMH) burden and cognitive function across the CKM spectrum remains unclear. METHODS: We performed a retrospective cross-sectional analysis of adults with CKM syndrome who underwent brain MRI and cognitive testing using the Cognitive Abilities Screening Instrument (CASI) and the Mini-Mental State Examination (MMSE). The WMH burden was graded using the Fazekas scale, and cognitive impairment was defined using age- and education-specific cutoffs. The CKM status was primarily assessed using a stage-based classification, and PREVENT-based CKM risk categories were evaluated in an exploratory subset. Associations between cognitive function and WMH burden were examined using multivariable proportional-odds regression models. RESULTS: CASI- and MMSE-defined cognitive impairment was present in 70.3% and 65.9% of 1,217 participants with advanced CKM syndrome, respectively. In fully adjusted models, increases in the CASI and MMSE scores of one standard deviation were associated with lower probabilities of a greater periventricular WMH burden (odds ratio [OR]=0.69 and 95% confidence interval [CI]=0.60-0.79, and OR=0.68 and 95% CI=0.59-0.78, respectively) and deep WMH burden (OR=0.76 and 95% CI=0.67-0.86, and OR=0.75 and 95% CI=0.66-0.85, respectively). A higher CKM stage was associated with worse cognitive function and greater WMH burden; similar exploratory patterns were observed in the smaller subset with available PREVENT-based CKM risk classifications. CONCLUSIONS: The WMH burden is associated with cognitive impairment across the CKM spectrum, suggesting that the WMH burden reflects brain vulnerability related to metabolic dysfunction.
doi.org/10.3988/jcn.2026.0136Open accessPubMed 43039411Biomarkers